The fears that the downward spiral of the capital markets during the financial crisis that occurred in 2008 would be repeated in the wake of last week's "Black Monday" are, for the time being, in the rearview mirror. more »
What's in a name? A core drug substance and a four-letter alphabet soup suffix. That's the FDA's proposal for nonproprietary, or "proper," names for reference biologics and biosimilars.
- Valeant fills Amgen gap as Astrazeneca hands off brodalumab; $100M up front
- 'Patients' pays off for Trevena pain phase IIb as TRV130 score keen over morphine – again
- Heat seeks spark in checkpoint inhibitors
- Exscientia delivers first compound in Sumitomo deal within 12 months
- Stem cell regulations easing China's move toward cell therapy
- Chinese biopharmas survive Black Monday, but report slowed growth in 1H 2015
- Stem cell regulations easing China’s move toward cell therapy
- Sucampo buying Japan’s R-Tech Ueno to set stage for growth, diversification
- Phospholipid directs neuron organization in spinal cord
- Takeda’s vaccines unit secures rights as globa...
The fears that the downward spiral of the capital markets during the financial crisis that occurred in 2008 would be repeated in the wake of last week's "Black Monday" are, for the time being, in the rearview mirror. In fact, the markets have rebounded strongly and now seem poised to remain positive for the final months of the year, although it is predicted there will be some turbulence along the way.
In genomewide association studies (GWAS), a variant in the gene FTO is the strongest obesity-correlated signal in the human genome.
Since it was first flagged by GWAS seven years ago, though, why FTO is so strongly linked to obesity has remained a puzzle.
Now, scientists have dissected the cellular circuitry that is affected by FTO. Their work both suggests new obesity targets and could serve as a general roadmap for how to understand the effects of variants in noncoding regions of the genome.READ MORE »
- Phospholipid directs neuron organization in spinal cord »
- Pyruvates of the Caribbean slay tumors »
- New insights into relationship between pain and depression »
- Androgen receptor finding key to prostate cancer drug design »
- New antigens could provide broader influenza protection »
- Unleashing immune system moves from cancer to neurodegeneration »
- GITR antibody-mediated cancer immunotherapies mechanism described »
- Method expands adaptive data analysis »
- Chemical reprogramming can transform skin cells into neurons »
- Lessons learned from You-Know-WhoSeptember 02, 2015 | 4:47 PM | Posted by: Mari Serebrov
- The next episode of the American horror storyJuly 24, 2015 | 9:10 PM | Posted by: Mari Serebrov
- Utopia, dystopia: Separating truth from fiction in bioethics discussionsJune 03, 2015 | 12:05 AM | Posted by: Jennifer Boggs
- A world of intrigue, from Missoula to Mars: BioWorld’s 9th Annual Summer Reading ListMay 26, 2015 | 6:31 PM | Posted by: Marie Powers
- You’ve come a long way, baby, but still a long way to goMay 04, 2015 | 2:44 PM | Posted by: Mari Serebrov
Partners in Focus
Cast Your Vote
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter